sinc
middecemb
coronaviru
diseas
spread
wuhan
china
confirm
patient
south
korea
came
visit
china
secondari
transmiss
occur
speed
transmiss
acceler
rise
concern
commun
infect
old
male
third
patient
diagnos
korea
worker
cloth
busi
mild
respiratori
symptom
intermitt
fever
begin
hospit
pneumonia
symptom
chest
computer
tomographi
scan
day
admiss
patient
caus
one
case
secondari
transmiss
three
case
tertiari
transmiss
herebi
report
clinic
find
index
patient
first
caus
tertiari
transmiss
outsid
china
interestingli
lopinavirritonavir
kaletra
abbvi
administ
viral
load
significantli
decreas
littl
coronaviru
titer
observ
korean
man
live
wuhan
china
enter
korea
januari
felt
first
symptom
chill
muscl
pain
januari
contact
public
health
center
januari
isol
neg
pressur
room
myongji
hospit
confirm
januari
time
initi
confirm
made
pancoronaviru
convent
polymeras
chain
reaction
assay
sequenc
polymeras
chain
reaction
pcr
amplicon
use
throat
swab
index
patient
transmit
viru
friend
patient
restaur
day
symptom
patient
confirm
januari
transmit
spous
son
confirm
januari
church
colleagu
confirm
februari
first
case
tertiari
transmiss
outsid
china
index
patient
cloth
worker
wuhan
fashion
center
height
cm
weight
kg
bodi
mass
index
major
ill
deni
smoke
drink
histori
admiss
day
respiratori
symptom
blood
pressur
mmhg
puls
rate
beat
per
minut
respiratori
rate
breath
per
minut
bodi
temperatur
physic
examin
pharyng
inject
clear
lung
sound
hazi
chest
xray
observ
test
leptospira
hantan
viru
tsutsugamushi
malaria
tuberculosi
human
immunodefici
viru
hiv
agab
vener
diseas
research
laboratori
vdrl
test
neg
develop
fever
dri
cough
day
ill
respect
seriou
respiratori
symptom
short
breath
product
sputum
chest
pain
small
consolid
right
upper
lobe
groundglass
opac
lower
lobe
observ
highresolut
comput
tomographi
scan
fig
tabl
initi
viral
load
could
measur
realtim
pcr
avail
patient
diagnos
measur
viral
load
use
quantit
revers
transcript
rt
pcr
sinc
jan
viral
rna
extract
sputum
use
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
accord
manufactur
instruct
quantit
realtim
pcr
amplif
perform
use
quantstudio
appli
biosystem
foster
citi
ca
usa
realtim
pcr
kit
kogenebiotech
seoul
korea
report
lopinavirritonavir
kaletra
abbvi
treatment
lopinavirritonavir
start
hospit
day
day
ill
tablet
lopinavir
mgritonavir
mg
given
per
oral
bid
interestingli
next
day
lopinavirritonavir
administr
viral
load
start
decreas
detect
littl
coronaviru
titer
observ
sinc
fig
supplementari
fig
possibl
decreas
load
result
natur
cours
heal
process
rather
administr
lopinavirritonavir
therefor
data
need
collect
figur
direct
effect
lopinavirritonavir
treatment
patient
also
complain
psychiatr
symptom
depress
insomnia
suicid
thought
isol
patient
experienc
stress
regard
peopl
reaction
media
report
patient
addit
despit
mild
symptom
case
isol
neg
pressur
room
treatment
might
one
case
show
may
induc
rel
mild
symptom
patient
recov
earli
diagnosi
pneumonia
made
lopinavirritonavir
use
found
reduc
viral
load
improv
clinic
symptom
treatment
lopinavirritonavir
recommend
rel
highrisk
group
pneumonia
elderli
patient
patient
underli
diseas
earli
stage
need
evid
prove
clinic
efficaci
lopinavirritonavir
base
well
control
clinic
trial
imag
publish
agreement
patient
myongji
hospit
institut
review
board
irb
approv
studi
irb
written
inform
consent
given
patient
thank
myongji
hospit
staff
effort
cope
cancerrop
co
ltd
provid
test
diagnost
kit
measur
viru
titer
